Flexion Therapeutics — Q1 2019 Earnings Presentation
8 slides from Flexion Therapeutics's earnings presentation, May 8, 2019
Slide 1: Commercial Metrics Overview
Commercial Metrics Overview May 8, 2019 Exhibit 99.2
Slide 2: Commercial Metrics Overview
Commercial Metrics Overview ZILRETTA® net sales of $10.6 million in the first quarter of 2019 Preliminary ZILRETTA net sales of $5.1 million in April 2019 We have called on almost all of our 4,100 target accounts 2,247 accounts have purchased ZILRETTA, as of March 31, 2019; up from 1,837, as of Dece
Slide 3: ZILRETTA Net Sales Quarterly
ZILRETTA Net Sales Quarterly Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies.
Slide 4: Distribution of Accounts by ZILRETTA Purchases Cumulative
Distribution of Accounts by ZILRETTA Purchases Cumulative Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies; accounts purchase ZILRETTA directly from these specialty distributors and pharmacies.
Slide 5: Distribution of ZILRETTA Purchases by Accounts Cumulative
Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies; accounts purchase ZILRETTA directly from these specialty distributors and pharmacies. Distribution of ZILRETTA Purchases by Accounts Cumulative
Slide 6: Purchases by New and Existing Accounts Cumulative
ZILRETTA Purchases by New and Existing Accounts Cumulative Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies; accounts purchase ZILRETTA directly from these specialty distributors and pharmacies.
Slide 7: Purchases and Samples Shipped Quarterly
ZILRETTA Purchases and Samples Shipped Quarterly Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies; accounts purchase ZILRETTA directly from these specialty distributors and pharmacies.
Slide 8: Flexion: Transformative Medicine... Where It Matters
clevion Transformative Medicine... Where It Matters